|
|
||||||||
Papers In Press, published online ahead of print February 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Institut of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University, Graz 8010
Corresponding Author: sasa.frank{at}meduni-graz.at
Mature endothelial lipase (EL) is a 68 kDa-glycoprotein. In HepG2 cells infected with adenovirus encoding human EL, the mature EL was detectable in the cell lysates and heparin releasable fractions. In contrast, cell media of these cells contained two EL-fragments: a N-terminal 40 kDa- and a C-terminal 28 kDa-fragment. N-terminal protein sequencing of the His-tagged 28 kDa-fragment revealed that EL is cleaved on the C-terminus of the sequence R-N-K-R330Ø, the consensus cleavage sequence for mammalian proprotein convertases (pPCs). Replacement of Arg330, with Ser by site directed mutagenesis totally abolished EL-processing. EL-processing could efficiently be attenuated by specific inhibitors of pPCs,
1-Antitrypsin Portland (
1-PDX) and
1-Antitrypsin variant AVRR. Co-expression of PCs furin, PC6A and PACE4 with EL, resulted in a complete conversion of the full-length EL to truncated 40 kDa-fragment. Exogenously added EL was also processed by cells and the processing could be attenuated by
1-PDX. The expressed N-terminal 40 kDa-fragment of EL (EL-40) harboring the catalytic site, failed to hydrolyze 14C-NEFA from 14C -dipalmitoyl-phosphatidycholine (PC)- labeled HDL. EL-40 was incapable of bridging 125I-labeled HDL to the cells and had no impact on the plasma lipid concentration when overexpressed in mice. Thus, our results demonstrate that pPCs are involved in the inactivation process of EL.
This article has been cited by other articles:
![]() |
G. Mayer, J. Hamelin, M.-C. Asselin, A. Pasquato, E. Marcinkiewicz, M. Tang, S. Tabibzadeh, and N. G. Seidah The Regulated Cell Surface Zymogen Activation of the Proprotein Convertase PC5A Directs the Processing of Its Secretory Substrates J. Biol. Chem., January 25, 2008; 283(4): 2373 - 2384. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gauster, U. Hiden, A. Blaschitz, S. Frank, U. Lang, G. Alvino, I. Cetin, G. Desoye, and C. Wadsack Dysregulation of Placental Endothelial Lipase and Lipoprotein Lipase in Intrauterine Growth-Restricted Pregnancies J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2256 - 2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-H. Koo, J.-M. Longpre, R. P. T. Somerville, J. P. Alexander, R. Leduc, and S. S. Apte Regulation of ADAMTS9 Secretion and Enzymatic Activity by Its Propeptide J. Biol. Chem., June 1, 2007; 282(22): 16146 - 16154. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nour, G. Mayer, J. S. Mort, A. Salvas, M. Mbikay, C. J. Morrison, C. M. Overall, and N. G. Seidah The Cysteine-rich Domain of the Secreted Proprotein Convertases PC5A and PACE4 Functions as a Cell Surface Anchor and Interacts with Tissue Inhibitors of Metalloproteinases Mol. Biol. Cell, November 1, 2005; 16(11): 5215 - 5226. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |